Michal Begin
3Patents
1h-index
3Co-inventors
33Inventor score
Filing activity: Dec 23, 2007 → Jan 29, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8455450B2 | Methods for obtaining a therapeutically effective amount of hematopoietic precursor cells and long term engraftment thereof | Human Necessities | 14 | Active |
| US8765683B2 | T-140 peptide analogs having CXCR4 super-agonist activity for cancer therapy | Human Necessities | 1 | Active |
| US8663651B2 | T-140 peptide analogs having CXCR4 super-agonist activity for immunomodulation | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.